Cardiac Pacemakers, Inc.

Boston Scientific Scimed, Inc.

Other

Remon Medical Technologies, Ltd.

Keith R Maile

Jeffrey E Stahmann

William J Linder

Michael John Kane

Benjamin J Haasl

Paul J Huelskamp

Brendan Early Koop

Pramodsingh Hirasingh Thakur

Brian L Schmidt

Bin Mi

Ron A Balczewski

Lance Eric Juffer

Qi An

Jacob M Ludwig

Krzysztof Z Siejko

Allan Charles Shuros

John D Hatlestad

Dana Sachs

David J Ternes

Michael J Root

Yinghong Yu

Nick A Youker

John M Edgell

Abhi Chavan

Arthur J Foster

Stephen John Hahn

Devon N Arnholt

James Michael English

Jan Weber

James O Gilkerson

David L Perschbacher

Gerrard Merrill Carlson

Viktoria A Averina

Deepa Mahajan

Jay A Warren

Ramesh Wariar

Howard D Simms, Jr

Dennis Eric Larson

David A Chizek

Aleksandra Kharam

Moira B Sweeney

Abhijeet V Chavan

Benjamin Keith Stein

Stephen B Ruble

Jean M Bobgan

Binh C Tran

Robert S Harguth

Cheng Zhang

Ramprasad Vijayagopal

Amy Jean Brisben

Nicholas J Stessman

Sasidhar Vajha

Brian D Soltis

Eyal Doron

James E Blood

Bryan J Swackhamer

Yingbo Li

Jonathan Bennett Shute

Ignacio Chi

John E Hansen

Aaron Lewicke

David Nghiem

Thomas Piaget

Jason J Hamann

Scott R Stubbs

Lili Liu

Juan Gabriel Hincapie Ordonez

Keith L Herrmann

Benjamin R Fruland

James M Peck

Eric E Bielefeld

Greg Paul Carpenter

Sarah Melissa Gruba

Larry D Canady

Robert Allen Jones

Wangcai Liao

Prashant K Singh

Scot C Boon

John J Stronczer

Michael W Dooley

Gregory J Sherwood

James Kalgren

Sunipa Saha

G Shantanu Reddy

Jeffrey Allen Von Arx

Craig Michael Stolen

Masoud Ameri

David W Kelly

Avi Penner

Arjun D Sharma

Danielle Frankson

Paul F Emerson

Jonathan H Kelly

Abraham Penner

Francis Wang

Daniel Ewert

Scott C Meyerson

Hua Wang

Rezwan Ahmed

Douglas J Gifford

Disclosed are medical devices with an acceleration sensor configured to generate acceleration data, a processor, and a memory. The memory, which may be a non-transitory computer readable medium, contains computer-executable instructions that, when executed by the processor, causes the processor to perform the following: obtain the acceleration data from a first range of time and a second range of time different from the first range, generate heart sound data based on the acceleration data, and determine that the medical device has flipped in orientation during the second range of time by comparing the heart sound data obtained during the first range of time with the heart sound data obtained during the second range of time.

Systems and methods for detecting implantable device rotation via heart sound morphology

Embodiments herein relate to devices and methods for assessing pulmonary congestion using optical sensing techniques. In an embodiment, a pulmonary congestion monitoring device can be included having a first optical emitter, wherein the first optical emitter can be configured to emit light at a first wavelength, such as at a near-infrared wavelength or an ultraviolet wavelength. The monitoring device can also include a first optical detector configured to detect incident light. The first optical emitter and the first optical detector can be separated by a distance of 1 centimeters (cm) to 10 cm. The monitoring device can be configured so that the light from the first optical emitter propagates through at least one of a lung tissue and an airway tissue. The monitoring device can also be configured to use detected incident light to determine a congestion status of the lung tissue. Other embodiments are also included herein.

Devices and methods for assessing pulmonary congestion using optical sensing

A medical system may include a left atrial appendage closure device including an expandable framework and a proximal hub disposed along a central longitudinal axis of the expandable framework, the expandable framework being configured to shift between a collapsed delivery configuration and an expanded deployed configuration; wherein the left atrial appendage closure device includes a sensor at least partially disposed within an interior of the expandable framework and axially movable relative to the proximal hub; wherein the proximal hub includes a first threaded connection structure; and a delivery catheter including a core wire extending axially within a lumen of the delivery catheter, the core wire having a second threaded connection structure at a distal end thereof configured to releasably engage the first threaded connection structure in an unreleased configuration and the second threaded connection structure is disengaged from the first threaded connection structure in a released configuration.

Medical system for treating a left atrial appendage

Improved devices, circuits and methods of operation in implantable stimulus systems. An implantable defibrillator may comprise an H-bridge output circuit having low and high sides, with a current controlling circuit coupled to the high side of the H-bridge output circuit and a current monitoring circuit coupled to the low side of the H-bridge output circuit. Alternate current paths to the output of the H-bridge, or to the H-Bridge itself, are used for delivering different therapies to the patient.

Output circuitry for multiple-therapy implantable devices

A medical system for monitoring a left atrial pressure in a heart of a patient may include an implantable device including an expandable framework and a first sensor secured to the expandable framework and an external component configured to communicate wirelessly with the implantable device. The first sensor may be configured to detect a first measurement. The first sensor may be a pressure sensor and the first measurement may be the left atrial pressure. The implantable device or the external component may include a processor configured to create a first trend for the first measurement. The processor may be configured to use the first trend to modify the first measurement prior to outputting a corrected result.

An implantable medical device may include each of a conductive canister, a printed circuit board assembly (PCBA), and a header. A feedthrough and ferrule couple the interior of the canister, where the PCBA is, to one or more elements contained in the header such as an antenna and/or a port for coupling to a lead. The ferrule may be directly attached to the conductive canister and the electronic circuit board. The electronic circuit board carries an RF transmitter for telemetry purposes, and has an RF ground plane layer therein. The ferrule is capacitively coupled to the RF ground plane the PCBA, and has a size and/or shape relative to the RF ground plane that provides sufficient capacitance to offer an improved RF ground plane path to the conductive canister at a desired telemetry frequency.

Implantable medical device with feedthrough antenna ground structure

Embodiments herein relate to a medical device for treating a cancerous tumor, the medical device having a first lead including a first wire and second wire; a second lead can include a third wire and fourth wire; and a first electrode in electrical communication with the first wire, a second electrode in electrical communication with the second wire, a third electrode in electrical communication with the third wire, and a fourth electrode in electrical communication with the fourth wire. The first and third electrodes form a supply electrode pair configured to deliver one or more electric fields to the cancerous tumor. The second and fourth electrodes form a sensing electrode pair configured to measure an impedance of the cancerous tumor independent of an impedance of the first electrode, the first wire, the third electrode, the third wire, and components in electrical communication therewith. Other embodiments are also included herein.

Electrical stimulation devices for cancer treatment

Embodiments of the present disclosure relate to implantable medical device (IMD) enclosures. In an exemplary embodiment, an IMD comprises: a housing comprising an open end and a header defining a cavity and comprising at least one conduit through a wall of the header, wherein the header is formed from a non-conductive material. Further, the IMD comprises a coupling member comprising a flange, wherein the flange is configured to be received by the open end of the housing and wherein the flange and the open end of the housing at least partially overlap along an axial direction of the IMD when the flange is received by the open end. Additionally, the IMD comprises an electrode arranged on an outer surface of the header and a feedthrough coupled to the electrode and extending through the conduit of the header, wherein the feedthrough is configured to be coupled to internal circuitry housed within the IMD. Further, the IMD comprises a ring forming a hermetic seal between the coupling member and the header.

IMD enclosure formed using dielectric materials incorporating feedthru(s)

Embodiments herein relate to medical devices and methods for using the same to treat cancerous tumors within a bodily tissue. A medical device system is included having at least one electric field generating circuit configured to generate one or more electric fields; control circuitry in communication with the electric field generating circuit, the control circuitry configured to control delivery of the one or more electric fields from the at least one electric field generating circuit; and two or more electrodes to deliver the electric fields to the site of a cancerous tumor within a patient. At least one electrode can be configured to be implanted. At least one electrode can be configured to be external. The control circuitry can cause the electric field generating circuit to generate one or more electric fields at frequencies selected from a range of between 10 kHz to 1 MHz.

Electrical stimulation for cancer treatment with internal and external electrodes

Implantable leadless pacing devices and medical device systems including an implantable leadless pacing device are disclosed. An example implantable leadless pacing device may include a pacing capsule. The pacing capsule may include a housing. The housing may have a proximal region and a distal region. A first electrode may be disposed along the distal region. One or more anchoring members may be coupled to the distal region. The anchoring members may each include a region with a compound curve.

Leadless cardiac pacing devices

An implantable medical device (IMD) is configured with a pressure sensor. The IMD includes a housing and a diaphragm that is exposed to the environment outside of the housing. The diaphragm is configured to transmit a pressure from the environment outside of the housing to a piezoelectric membrane. In response, the piezoelectric membrane generates a voltage and/or a current, which is representative of a pressure change applied to the housing diaphragm. In some cases, only changes in pressure over time are used, not absolute or gauge pressures.

Implantable medical device with pressure sensor

Embodiments herein relate to a method for treating a cancerous tumor located within a subject. The method can include applying one or more electric fields at or near a site of the cancerous tumor, where the cancerous tumor can include a cancerous cell population. The one or more applied electric fields are effective to delay mitosis and cause mitotic synchronization within a proportion of the cancerous cell population. The method can include removing the one or more electric fields to allow mitosis to proceed within the cancerous cell population. The method can include administering a chemotherapeutic agent to the subject after the one or more electric fields have been removed. Other embodiments are also included herein.

Combination electrical and chemotherapeutic treatment of cancer

Systems and methods for monitoring patients with a chronic disease such as heart failure are disclosed. The system may include a physiological sensor circuit to sense physiological signals and generate signal metrics from the physiological signals. The system may include a health status analyzer circuit to use the signal metrics to generate one or more stability indicators of patient health status, such as stability of heart failure status. The system may additionally generate one or more health status indicators indicating patient health status such as heart failure progression. A patient disposition decision may be generated using the health status indicators and the stability indicators to provide an indication of readiness for patient discharge from or a risk of admission to a hospital.

Systems and methods for patient monitoring

Improved devices, circuits and methods of operation in implantable stimulus systems. An implantable defibrillator may comprise a charging circuit using a transformer to store and build up energy on an HV capacitor or capacitor stack, with the HV capacitor in turn coupled to an H-bridge output circuit having low and high sides for issuing therapy. A current monitoring circuitry is provided on the low side of the H-Bridge and used to form a feedback loop to control current into a transformer that converts battery voltage to a signal that charges the HV capacitor to control current through the H-bridge.

High voltage therapy system with transformer primary current control

This document discusses, among other things, systems and methods to determine an indication of contractility of a heart of a patient using received physiologic information, and to determine blood pressure information of the patient using the heart sound information and the determined indication of contractility of the heart. The system can include an assessment circuit configured to determine an indication of contractility of a heart of the patient using first heart sound (S) information of the patient, and to determine blood pressure information of the patient using second heart sound (S) information of the patient and the determined indication of contractility of the heart.

Chronic monitoring of blood pressure using heart sounds

Growing community of inventors

New Brighton, MN, United States of America

Keith R Maile